Novartis looks past psoriasis for even bigger Cosentyx growth frontier
admin 14th November 2017 Uncategorised 0Novartis’ Cosentyx currently leads a crop of next-gen immunology products from a who’s who of Big Pharma. And the Swiss drugmaker intends to keep it that way.
More: Novartis looks past psoriasis for even bigger Cosentyx growth frontier
Source: fierce